Back to Top

Ask about this


Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain

  • Carmen de Mendoza 1
  • Estrella Caballero 2
  • José María Eiros 3
  • Silvia Rojo 4
  • Rafael Benito 5
  • Vicente Soriano 6
  • 1 - Internal Medicine Department - Puerta de Hierro University Hospital and Research Institute - Madrid Spain
  • 2 - Microbiology Department - Hospital Vall d'Hebrón - Barcelona Spain
  • 3 - Microbiology Department - Rio Hortega University Hospital - Valladolid Spain
  • 4 - Microbiology Department - Clinical University Hospital - Valladolid Spain
  • 5 - Microbiology Department - Hospital Clínico Universitario Lozano Blesa - Zaragoza Spain
  • 6 - Infectious Diseases and Genetics Department - UNIR Health Sciences School and Medical Center - Madrid Spain


The medical demand imposed by COVID-19 has distracted proper care of other illnesses. Herein, we report the impact on new diagnoses of HTLV-1, HTLV-2, and HIV-2 in Spain, where these infections are mostly driven by immigration flows from endemic regions. As expected, case reporting declined for all three retroviral infections with respect to prior years. Furthermore, late presentations were more common. The two major reasons for these observations were significant declines in the arrival of foreigners from endemic regions and a shift in medical resources to prioritize COVID-19.



Be the first to comment on this protocol.

Submit a Comment

First Name *

Last Name *

Email *

Comments *

By submitting this form, you agree to the Genetic Engineering & Biotechnology News (GEN) privacy policy.